Deep dissection of stemness-related hierarchies in hepatocellular carcinoma

被引:5
|
作者
Liang, Rui [1 ]
Hong, Weifeng [2 ]
Zhang, Yang [3 ]
Ma, Di [1 ]
Li, Jinwei [4 ]
Shi, Yisong [1 ]
Luo, Qing [1 ]
Du, Shisuo [2 ]
Song, Guanbin [1 ]
机构
[1] Chongqing Univ, Coll Bioengn, Key Lab Biorheol Sci & Technol, Minist Educ, Chongqing 400030, Peoples R China
[2] Fudan Univ, Zhongshan Hosp, Dept Radiat Oncol, 180 Fenglin Rd, Shanghai, Peoples R China
[3] Dali Univ, Affiliated Hosp 1, Gen Surg 1, Dali 671000, Peoples R China
[4] Guangxi Med Univ, Dept Neurosurg, Affiliated Hosp 4, Liuzhou 545000, Guangxi, Peoples R China
关键词
Hepatocellular carcinomas; Stemness; Molecule subtypes; Prognosis; Tumor microenvironment; Immunotherapy; Immune infiltration; mRNAsi; scRNA-seq; LPCAT1; LYSOPHOSPHATIDYLCHOLINE ACYLTRANSFERASE 1; CANCER; CELLS; PROGRESSION; EVOLUTION; HALLMARK; GROWTH; ATLAS; NICHE;
D O I
10.1186/s12967-023-04425-8
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
BackgroundIncreasing evidence suggests that hepatocellular carcinoma (HCC) stem cells (LCSCs) play an essential part in HCC recurrence, metastasis, and chemotherapy and radiotherapy resistance. Multiple studies have demonstrated that stemness-related genes facilitate the progression of tumors. However, the mechanism by which stemness-related genes contribute to HCC is not well understood. Here, we aim to construct a stemness-related score (SRscores) model for deeper analysis of stemness-related genes, assisting with the prognosis and individualized treatment of HCC patients.Further, we found that the gene LPCAT1 was highly expressed in tumor tissues by immunohistochemistry, and sphere-forming assay revealed that knockdown of LPCAT1 inhibited the sphere-forming ability of hepatocellular carcinoma cells.MethodsWe used the TCGA-LIHC dataset to screen stemness-related genes of HCC from the MSigDB database. Prognosis, tumor microenvironment, immunological checkpoints, tumor immune dysfunction, rejection, treatment sensitivity, and putative biological pathways were examined. Random forest created the SRscores model. The anti-PD-1/anti-CTLA4 immunotherapy, tumor mutational burden, medication sensitivity, and cancer stem cell index were compared between the high- and low-risk score groups. We also examined risk scores for different cell types using single-cell RNA sequencing data and correlated transcription factor activity in cancer stem cells with SRscores genes. Finally, we tested core marker expression and biological functions.ResultsPatients can be divided into two subtypes (Cluster1 and Cluster2) based on the TCGA-LIHC dataset's identification of 11 stemness-related genes. Additionally, a SRscores was developed based on subtypes. Cluster2 and the group with the lowest SRscores had superior survival and immunotherapy response than Cluster1 and the group with the highest SRscores. The group with a high SRscores was significantly more enriched in classical tumor pathways than the group with a low SRscores. Multiple transcription factors and SRscores genes are correlated. The core gene LPCAT1 is highly expressed in rat liver cancer tissues and promotes tumor cell sphere formation.ConclusionA SRscores model can be utilized to predict the prognosis of HCC patients as well as their response to immunotherapy.
引用
收藏
页数:18
相关论文
共 50 条
  • [41] Terpenoids from quinoa reverse chemoresistance in breast cancer by suppressing the stemness-related lncRNA 667012
    Fan, Xiaxia
    Feng, Mangmang
    Guo, Dan
    Li, Songtao
    An, Yuxuan
    Tian, Jinmiao
    Li, Zhuoyu
    FOOD FRONTIERS, 2025, 6 (01): : 516 - 531
  • [42] Implications of stemness-related signaling pathways in breast cancer response to therapy
    Angeloni, Valentina
    Tiberio, Paola
    Appierto, Valentina
    Daidone, Maria Grazia
    SEMINARS IN CANCER BIOLOGY, 2015, 31 : 43 - 51
  • [43] Stemness-related gene signatures as a predictive tool for breast cancer radiosensitivity
    Lai, Jinzhi
    Huang, Rongfu
    Huang, Jingshan
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [44] Integrated Multi-Omics Data Analysis Reveals Associations Between Glycosylation and Stemness in Hepatocellular Carcinoma
    Liu, Peiyan
    Zhou, Qi
    Li, Jia
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [45] An integrated investigation of sulfotransferases (SULTs) in hepatocellular carcinoma and identification of the role of SULT2A1 on stemness
    Peng, Hao
    Feng, Kun
    Jia, Weilu
    Li, Yunxin
    Lv, Qingpeng
    Zhang, Yewei
    APOPTOSIS, 2024, 29 (5-6) : 898 - 919
  • [46] A novel stemness-hypoxia-related signature for prognostic stratification and immunotherapy response in hepatocellular carcinoma
    Genhao Zhang
    Kai Zhang
    Yanteng Zhao
    Qiankun Yang
    Xianping Lv
    BMC Cancer, 22
  • [47] A novel stemness-hypoxia-related signature for prognostic stratification and immunotherapy response in hepatocellular carcinoma
    Zhang, Genhao
    Zhang, Kai
    Zhao, Yanteng
    Yang, Qiankun
    Lv, Xianping
    BMC CANCER, 2022, 22 (01)
  • [48] Identification and Validation of Immune- and Stemness-Related Prognostic Signature of Melanoma
    Zhang, Yan
    Peng, Jing
    Du, Heng
    Zhang, Niannian
    Fang, Xianfeng
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [49] Novel Stemness-Related Gene Signature Predicting Prognosis and Indicating a Different Immune Microenvironment in HNSCC
    Luo, Yi
    Xu, Wei-Bo
    Ma, Ben
    Wang, Yu
    FRONTIERS IN GENETICS, 2022, 13
  • [50] Identification of a stemness-related gene panel associated with BET inhibition in triple negative breast cancer
    Serrano-Oviedo, Leticia
    Nuncia-Cantarero, Miriam
    Morcillo-Garcia, Sara
    Nieto-Jimenez, Cristina
    Burgos, Miguel
    Corrales-Sanchez, Veronica
    Perez-Pena, Javier
    Gyorffy, Balazs
    Ocana, Alberto
    Maria Galan-Moya, Eva
    CELLULAR ONCOLOGY, 2020, 43 (03) : 431 - 444